Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has shared an announcement.
PharmaCorp Rx Inc. has announced its agreement to acquire a pharmacy business in Western Canada for $2.4 million, marking a strategic expansion of its operations. This acquisition, expected to close by July 31, 2025, underscores PharmaCorp’s commitment to growth through strategic alliances and acquisitions, enhancing its platform and market presence in the Canadian pharmaceutical sector.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on acquiring and managing pharmacies under the PharmaChoice Canada banner. The company is actively involved in expanding its operations by acquiring both PharmaChoice and independently owned pharmacies across Canada. PharmaCorp is listed on the TSX Venture Exchange under the symbol PCRX.
Average Trading Volume: 23,097
Technical Sentiment Signal: Buy
Current Market Cap: C$44.76M
See more insights into PCRX stock on TipRanks’ Stock Analysis page.